FREDUN₹1,368.40-1.62%
70/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %FREDUN financial summary
For Mar 2026, Fredun Pharmaceuticals Ltd reported revenue of ₹635 crore, which grew 39.9% from the previous year. Net profit was ₹33 crore, which grew 57.1% year on year, on an operating margin of 14%. Earnings per share came in at ₹20.25. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹635 crore |
|---|---|
| Net profit | ₹33 crore |
| Operating margin | 14% |
| EPS | ₹20.25 |